Mail & Guardian
Mail & Guardian
rhulani nhlanikilatest news & developments
On trial: About 800 people are part of a coronavirus vaccine trial by pharmaceutical giant Pfizer, headed by Rhulani Nhlaniki in South Africa. (Paul Botes/M&G)
BIOVAC INSTITUTE

Q&A Sessions: ‘My north star is the patient’

Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela…

  • Eyaaz Matwadia
7 min read